MSC-Derived Exosomes for Cartilage Repair: Clinical Trial Update

Skip to main content
< All Topics
Print

MSC-Derived Exosomes for Cartilage Repair: Clinical Trial Update

This paper provides an update on preclinical and clinical trials evaluating mesenchymal stem cell-derived exosomes for cartilage repair. The authors review the latest evidence supporting exosome therapy for joint diseases like osteoarthritis.

For patients exploring regenerative options for cartilage damage, this is a strong, current reference on where the science stands.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.

Table of Contents